Suchergebnisse - "Jarva, Hanna"

PubPharm (136)

1

Antibody responses to immunoevasion proteins BBK32 and OspE constitute part of the serological footprint in neuroborreliosis but are insufficient to prevent the disease

enthalten in: Scandinavian Journal of Immunology | 2024

von Dulipati, V. | Kotimaa, J. | Rezola, M. | +4

2

Evaluation of the Novel CE-IVD-Marked Multiplex PCR QIAstat-Dx Meningitis/Encephalitis Panel

enthalten in: Microbiology spectrum | 2023

von Humisto, A. | Antikainen, J. | Holma, T. | +4

3

FASCIA Method in the Assessment of Lymphocyte Mitogen Responses in the Laboratory Diagnostics of Primary Immunodeficiencies

enthalten in: Journal of clinical immunology | 2023

von Lusila, P. | Toivonen, A. | Jarva, H. | +3

4

Stable Levels of Antibodies Against Unrelated Toxoid Vaccines After COVID-19 : COVID-19 Infection Does Not Affect Toxoid Vaccine Antibody Levels

enthalten in: Pathogens & immunity | 2023

von Jokiranta, S. | Miettinen, S. | Salonen, S. | +14

5

FASCIA Method in the Assessment of Lymphocyte Mitogen Responses in the Laboratory Diagnostics of Primary Immunodeficiencies

enthalten in: Journal of clinical immunology | 2022

von Lusila, P. | Toivonen, A. | Jarva, H. | +3

6

FASCIA Method in the Assessment of Lymphocyte Mitogen Responses in the Laboratory Diagnostics of Primary Immunodeficiencies

enthalten in: Journal of clinical immunology | 2022

von Lusila, P. | Toivonen, A. | Jarva, H. | +3

7

Comparative evaluation of four commercial analyzers for the serological screening of hepatitis A, B, C and HIV

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022

von Kutvonen, H. | Jarva, H. | Lappalainen, M. | +1

8

Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2022

von Ahava, M. | Jarva, H. | Jääskeläinen, A. | +3

9

Introduction and Rapid Spread of SARS-CoV-2 Omicron Variant and Dynamics of BA.1 and BA.1.1 Sublineages, Finland, December 2021

enthalten in: Emerging infectious diseases | 2022

von Vauhkonen, H. | Nguyen, P. | Kant, R. | +22

10

FASCIA method in the assessment of lymphocyte mitogen responses in the laboratory diagnostics of primary immunodeficiencies

enthalten in: ResearchSquare.com | 2022

von Lusila, P. | Toivonen, A. | Jarva, H. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]